世界の血友病市場は2026年に158.6億ドルに達し、2022年から2026年までのCAGRは5.82％と予想されます。市場の成長を促す要因としては、医療費の増加、特定された血友病患者数の急増、予防的治療への注目の高まり、男性人口の増加、政府の戦略などが挙げられます。市場は、高額な治療費や新しい治療法への切り替えへの抵抗などの課題に直面することが予想されます。これらの課題を克服するために、新しい血友病治療法の開発や遺伝子治療の人気の高まりなど、いくつかの重要な動向が予想されます。
世界の血友病市場は治療レジメン別に、予防とオンデマンドに分類されます。2021年には、予防セグメントが高い割合を占め、次にオンデマンドセグメントが続きました。世界の血友病市場はタイプ別に血友病Aと血友病Bに分類できます。2021年には血友病Aが大きなシェアを占めました。治療法別には、補充療法とITI療法に分類されます。2021年における市場シェアの大半は補充療法のセグメントが占めました。
目次
1. Market Overview
1.1 Hemophilia
1.2 Types of Hemophilia
1.3 Signs & Symptoms
1.4 Diagnosis of Hemophilia
1.5 Treatment of Hemophilia
2. Impact of COVID-19
2.1 Impact on Global Economy
2.2 Global Prevalence of COVID-19
2.3 Impact on Healthcare Spending
2.4 Post-COVID Scenario
3. Global Market Analysis
3.1 Global Hemophilia Market by Value
3.2 Global Hemophilia Market Forecast by Value
3.3 Global Hemophilia Market by Treatment Regimen
3.4 Global Hemophilia Market by Type
3.4.1 Global Hemophilia A Market Forecast by Value
3.4.2 Global Hemophilia A Market by Severity
3.4.3 Global Hemophilia A Market by Treatment Type
3.4.4 Global Hemophilia A Market by Treatment Regimen
3.4.5 Global Hemophilia A Market Value by Treatment Regimen
3.4.6 Global Hemophilia B Market Forecast by Value
3.4.7 Global Hemophilia B Market by Severity
3.4.8 Global Hemophilia B Market by Treatment Type
3.4.9 Global Hemophilia B Market by Treatment Regimen
3.4.10 Global Hemophilia B Market Value by Treatment Regimen
3.5 Global Hemophilia Market by Therapy
3.5.1 Global Hemophilia Replacement Therapy Market Forecast by Value
3.5.2 Global Hemophilia ITI Therapy Market Forecast by Value
3.6 Global Hemophilia Market by Region
4. Regional Market Analysis
4.1 North America
4.1.1 North America Hemophilia Market by Value
4.1.2 North America Hemophilia Market Forecast by Value
4.1.3 The US Hemophilia Market by Value
4.1.4 The US Hemophilia Market Forecast by Value
4.1.5 The US Hemophilia Market by Type
4.1.6 The US Hemophilia A Market Forecast by Value
4.1.7 The US Hemophilia A Treated Patient Volume Forecast
4.1.8 The US Hemophilia A Severe Patients on Prophylactic Therapy
4.1.9 The US Hemophilia A Severe Patients on On-Demand Therapy
4.1.10 The US Hemophilia A Mild to Moderate Patients on Prophylaxis Therapy
4.1.11 The US Hemophilia A Mild to Moderate Patients on On-Demand Therapy
4.1.12 The US Hemophilia B Market Forecast by Value
4.1.13 The US Hemophilia B Treated Patients Volume Forecast
4.1.14 The US Hemophilia B Severe Patients on Prophylaxis Therapy
4.1.15 The US Hemophilia B Severe Patients on On-Demand Therapy
4.1.16 The US Hemophilia B Mild to Moderate Patients on Prophylaxis Therapy
4.1.17 The US Hemophilia B Mild to Moderate Patients on On-Demand Therapy
4.2 Europe
4.2.1 Europe Hemophilia Market by Value
4.2.2 Europe Hemophilia Market Forecast by Value
4.2.3 Europe Hemophilia Patient Volume Forecast
4.2.4 Europe Hemophilia A Patient Volume Forecast
4.2.5 Europe Hemophilia B Patient Volume Forecast
4.3 Asia Pacific
4.3.1 Asia Pacific Hemophilia Market by Value
4.3.2 Asia Pacific Hemophilia Market Forecast by Value
4.4 ROW
4.4.1 ROW Hemophilia Market by Value
4.4.2 ROW Hemophilia Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increased Focus on Prophylactic Treatment
5.1.2 Increasing Diagnosis Rate
5.1.3 Rise in Global Healthcare Expenditure
5.1.4 Rise in Male Population
5.1.5 Favourable Government Initiatives
5.2 Key Trends & Development
5.2.1 Shifting Focus to Extended Half Life Therapies
5.2.2 Development of Novel Hemophilia Treatments
5.2.3 Popularity of Gene Therapy
5.3 Challenges
5.3.1 High Cost of Treatment
5.3.2 Reluctance to Switch to New Therapies
6. Competitive Landscape
6.1 Global Market
6.1.1 Revenue Comparison - Key Players
6.1.2 Market Capitalization Comparison- Key Players
6.1.3 Research & Development Expenses Comparison - Key Players
6.1.4 Global Hemophilia A Market Share by Company
6.1.5 Global Hemophilia A Factor VIII Products Market Share by Company
6.1.6 Global Hemophilia A FVIII Gene Therapy Market Share Forecast
6.1.7 Global Hemophilia B Market Share by Company
6.1.8 Global Hemophilia B Factor IX Products Market Share Forecast
6.1.9 Global Hemophilia B Factor IX Gene Therapy Market Share Forecast
6.1.10 Key Players - Major Anti-Hemophilia Products
6.2 The US Market
6.2.1 The US Hemophilia A Market Share by Company
6.3 Europe Market
6.3.1 Europe Hemophilia A Market Share by Company
7. Company Profiles
7.1 Pfizer Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Bayer Group
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Sanofi S.A.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Takeda Pharmaceutical Company
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Novo Nordisk
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 CSL Limited
7.6.1 Business Overview
7.6.2 Financial Overview
7.6.3 Business Strategies
List of Figures
Types of Hemophilia
Diagnosis of Hemophilia
Global Coronavirus Prevalence (May’21 - Dec’21)
Global Hemophilia Market by Value (2017-2021)
Global Hemophilia Market Forecast by Value (2022-2026)
Global Hemophilia Market by Treatment Regimen (2021)
Global Hemophilia Market by Type (2021)
Global Hemophilia A Market Forecast by Value (2019-2026)
Global Hemophilia A Market by Severity (2021)
Global Hemophilia A Market by Treatment Type (2021)
Global Hemophilia A Market by Treatment Regimen (2021 & 2026)
Global Hemophilia A Market Value by Treatment Regimen (2019-2026)
Global Hemophilia B Market Forecast by Value (2019-2026)
Global Hemophilia B Market by Severity (2021)
Global Hemophilia B Market by Treatment Type (2021)
Global Hemophilia B Market by Treatment Regimen (2021 & 2026)
Global Hemophilia B Market Value by Treatment Regimen (2019-2026)
Global Hemophilia Market by Therapy (2021)
Global Hemophilia Replacement Therapy Market Forecast by Value (2019-2026)
Global Hemophilia ITI Therapy Market Forecast by Value (2019-2026)
Global Hemophilia Market by Region (2021)
North America Hemophilia Market by Value (2018-2021)
North America Hemophilia Market Forecast by Value (2022-2026)
The US Hemophilia Market by Value (2018-2021)
The US Hemophilia Market Forecast by Value (2022-2026)
The US Hemophilia Market by Type (2021)
The US Hemophilia a Market Forecast by Value (2019-2026)
The US Hemophilia a Treated Patient Volume Forecast (2019-2026)
The US Hemophilia a Severe Patients on Prophylactic Therapy (2019-2026)
The US Hemophilia a Severe Patients on On-Demand Therapy (2019-2026)
The US Hemophilia a Mild to Moderate Patients on Prophylaxis Therapy (2019-2026)
The US Hemophilia a Mild to Moderate Patients on On-Demand Therapy (2019-2026)
The US Hemophilia B Market Forecast by Value (2019-2026)
The US Hemophilia B Treated Patients Volume Forecast (2019-2026)
The US Hemophilia B Severe Patients on Prophylaxis Therapy (2019-2026)
The US Hemophilia B Severe Patients on On-Demand Therapy (2019-2026)
The US Hemophilia B Mild to Moderate Patients on Prophylaxis Therapy (2019-2026)
The US Hemophilia B Mild to Moderate Patients on On-Demand Therapy (2019-2026)
Europe Hemophilia Market by Value (2018-2021)
Europe Hemophilia Market Forecast by Value (2022-2026)
Europe Hemophilia Patient Volume Forecast (2019-2026)
Europe Hemophilia A Patient Volume Forecast (2019-2026)
Europe Hemophilia B Patient Volume Forecast (2019-2026)
Asia Pacific Hemophilia Market by Value (2018-2021)
Asia Pacific Hemophilia Market Forecast by Value (2022-2026)
ROW Hemophilia Market by Value (2018-2021)
ROW Hemophilia Market Forecast by Value (2022-2026)
Global Market Share of Hemophilia A and B Patients on Prophylaxis (2019 & 2023)
Global Identified Hemophilia Patients Volume (2016-2020)
Global Health Spending Per Capita (2017-2020)
Global Male Population (2016-2020)
Global Hemophilia A Market Share by Company (2021)
Global Hemophilia A Factor VIII Products Market Share by Company (2023/2030)
Global Hemophilia A FVIII Gene Therapy Market Share Forecast (2030)
Global Hemophilia B Market Share by Company (2021)
Global Hemophilia B Factor IX Products Market Share Forecast (2023/2030)
Global Hemophilia B Factor IX Gene Therapy Market Share Forecast (2030)
The US Hemophilia A Market Share by Company (2021)
Europe Hemophilia B Market Share by Company (2021)
Pfizer Inc. Revenue and Net Income (2016-2020)
Pfizer Inc. Revenue by Region (2020)
Bayer Group Net Sales and Net Income (2016-2020)
Bayer Group Net Sales by Segments (2020)
Bayer Group Net Sales by Region (2020)
Sanofi S.A. Net Sales and Net Income (2016-2020)
Sanofi S.A. Net Sales by Segment (2020)
Sanofi S.A. Net Sales by Region (2020)
Takeda Pharmaceutical Company Revenue and Net Income (2017-2021)
Takeda Pharmaceutical Company Revenue by Segment (2021)
Takeda Pharmaceutical Company Revenue by Region (2021)
Novo Nordisk Net Sales and Net Profit (2016-2020)
Novo Nordisk Net Sales by Segment (2020)
Novo Nordisk Net Sales by Region (2020)
CSL Limited Sales Revenue and Net Profit (2017-2021)
CSL Limited Sales Revenue by Segment (2021)
CSL Limited Sales Revenue by Region (2021)
List of Tables
Signs & Symptoms of Hemophilia
Extended Half Life Products
Development of New Novel Haemophilia Treatments
Hemophilia Gene Therapy Candidates Key Players - Revenue Comparison (2020/2021)
Key Players - Market Capitalization Comparison (2021)
Key Players - Research & Development Expenses Comparison (2020/2021)
Key Players - Main Anti-Hemophilia Products
